Market revenue in 2021 | USD 11.6 million |
Market revenue in 2028 | USD 29.6 million |
Growth rate | 14.3% (CAGR from 2021 to 2028) |
Largest segment | Adventitious virus tests |
Fastest growing segment | Adventitious Virus Tests |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Adventitious Virus Tests, Antibody Production Tests, Retrovirus Tests, Specific Virus Tests, Other Tests |
Key Regions: U.S. , Japan , Canada , China , South Korea
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to virus safety testing services market will help companies and investors design strategic landscapes.
Adventitious virus tests was the largest segment with a revenue share of 37.07% in 2021. Horizon Databook has segmented the Australia virus safety testing services market based on adventitious virus tests, antibody production tests, retrovirus tests, specific virus tests, other tests covering the revenue growth of each sub-segment from 2016 to 2028.
In Australia, biosafety rules and regulations are maintained by the Therapeutic Goods Administration (TGA), which is a part of the Australian Department of Health. The TGA provides guidelines for sterility testing of drugs supplied for human use.
Its rules are stringent and aid in maintaining high product quality. Associations such as Australian Pharmaceutical Manufacturing Association (APMA) operate in manufacturing, export, and research of pharmaceutical products, including biologics, which is expected to have a positive impact on growth of virus safety testing services market.
In addition, increasing public-private partnerships to fuel biologics R&D in Australia is further expected to create lucrative opportunities. In March 2020, U.S.-based Aragen Bioscience, Inc. collaborated with the University of Technology Sydney (UTS) to accelerate biologics R&D in Australia.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia virus safety testing services market , including forecasts for subscribers. This country databook contains high-level insights into Australia virus safety testing services market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account